Morpho (MORPHO) is currently trading at $1.13, experiencing a 24-hour decline of 2.25%. The daily price range has been relatively narrow, fluctuating between $1.12 and $1.16, indicating low volatility.

Trading volume stands at approximately 12.37 million, equating to a volume/market cap ratio of 2.03%, suggesting limited liquidity relative to its market capitalization. The hourly moving averages indicate bearish momentum, particularly with the 55 SMA at $1.18 showing a significant 4.11% decline, while longer-term SMAs also reflect negative trends.

Momentum indicators reveal an RSI of 48 for the past hour, which points to a neutral short-term outlook. In contrast, the 7-day RSI at 45 indicates oversold conditions, aligning with the 7-day price change of -8.28% and reinforcing the bearish sentiment over the past week.

Further analysis shows that Morpho's price has plummeted 23.93% over the last 14 days and 43.67% over the past 30 days, underscoring a strong downtrend. The all-time high of $4.17, reached in January 2025, seems increasingly distant, suggesting that current prices are significantly depressed.

Given the prevailing bearish momentum across multiple timeframes, alongside the low volume and negative price changes, the outlook remains negative. Therefore, I recommend a Sell rating for Morpho (MORPHO) as the price continues to trend downward with no immediate signs of recovery.